Philips continues research efforts with Lenox Hill Hospital

Philips Medical Systems will further its research initiatives with Lenox Hill Hospital.

Philips signed a two-year agreement with the hospital that enhances their partnership of nearly 15 years. The facility is a 652-bed acute-care hospital located on Manhattan's Upper East Side and home to the Lenox Hill Heart and Vascular Institute.

According to Philips, the plan is to co-develop interventional technologies that will deliver vital insight into the heart's anatomy and enable cardiologists to provide more thorough exams, diagnoses and treatment plans for cardiovascular patients.

Researchers will focus on a new image processing algorithm and how it can be used with Philips Allura Xper FD10 cath lab. Philips says the hope is to provide clinicians with enhanced images of the heart, enabling them to see lesions or growths in greater detail. In addition, Philips StentBoost, an interventional tool that allows clinicians to see stents in greater detail, will be evaluated to assess its value for stent placement and gauge its clinical efficacy.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup